Guide to using AAV vectors in gene therapy
Drug Discovery World
FEBRUARY 8, 2024
The event aimed to help the audience understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. Questions were fielded from the audience, which included: What analysis will be performed to evaluate host or other DNA contamination?
Let's personalize your content